| scholarly article | Q13442814 |
| P2093 | author name string | Ranju Ralhan | |
| K W Michael Siu | |||
| Ajay Matta | |||
| Olena Masui | |||
| Leroi V Desouza | |||
| Muzafar Macha | |||
| P2860 | cites work | Intestinal epithelial cells secrete exosome-like vesicles | Q24291534 |
| Identification and proteomic profiling of exosomes in human urine | Q24301829 | ||
| Exosomes with immune modulatory features are present in human breast milk | Q24321270 | ||
| Large-scale proteomics and phosphoproteomics of urinary exosomes | Q24321631 | ||
| Identification of differential proteins in nasopharyngeal carcinoma cells with p53 silence by proteome analysis | Q24337782 | ||
| Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation | Q24338441 | ||
| Cancer statistics, 2010 | Q27860525 | ||
| Improved prediction of signal peptides: SignalP 3.0 | Q27860548 | ||
| Multifunctional alpha-enolase: its role in diseases | Q28211999 | ||
| Clinical proteomics: Written in blood | Q28213537 | ||
| The human plasma proteome: history, character, and diagnostic prospects | Q28218148 | ||
| Feature-based prediction of non-classical and leaderless protein secretion | Q28259109 | ||
| The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma | Q30494514 | ||
| Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes | Q30644490 | ||
| Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study | Q31033878 | ||
| Molecular characterization of the tumor microenvironment in breast cancer | Q31095898 | ||
| Proteomics-based identification of proteins with altered expression induced by 12-O-tetradecanoylphorbol 13-acetate in nasopharyngeal carcinoma CNE2 cells | Q31145437 | ||
| 14-3-3 zeta protein secreted by tumor associated monocytes/macrophages from ascites of epithelial ovarian cancer patients | Q39962716 | ||
| Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry | Q39992556 | ||
| Identification of candidate biomarker proteins released by human endometrial and cervical cancer cells using two-dimensional liquid chromatography/tandem mass spectrometry | Q40128371 | ||
| Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis | Q40300675 | ||
| Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness. | Q40349236 | ||
| Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. | Q40476440 | ||
| Comprehensive gene expression profiling of anaplastic thyroid cancers with cDNA microarray of 25 344 genes. | Q40478097 | ||
| Identification of differentially expressed genes in oral squamous cell carcinoma. | Q40480504 | ||
| Establishment and characterization of a cell line from smokeless tobacco associated oral squamous cell carcinoma. | Q40633874 | ||
| Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles | Q40801310 | ||
| Evidence for heterogeneous nuclear ribonucleoprotein K overexpression in oral squamous cell carcinoma | Q43199301 | ||
| Identification of a gene signature for rapid screening of oral squamous cell carcinoma | Q44831594 | ||
| Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women. | Q45936703 | ||
| Proteomic identification of serum biomarkers for head and neck cancer surveillance. | Q46010717 | ||
| Absolute quantification of potential cancer markers in clinical tissue homogenates using multiple reaction monitoring on a hybrid triple quadrupole/linear ion trap tandem mass spectrometer | Q46073781 | ||
| Multiple reaction monitoring of mTRAQ-labeled peptides enables absolute quantification of endogenous levels of a potential cancer marker in cancerous and normal endometrial tissues | Q46481136 | ||
| Heterogeneous ribonucleoprotein k and thymidine phosphorylase are independent prognostic and therapeutic markers for nasopharyngeal carcinoma. | Q46535677 | ||
| Neuron-specific enolase and lung cancer | Q46827311 | ||
| Secretome-based identification of Mac-2 binding protein as a potential oral cancer marker involved in cell growth and motility | Q47438782 | ||
| Serum tumour markers in patients with chronic kidney disease. | Q51738013 | ||
| Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment. | Q51770293 | ||
| Nonlinear fitting method for determining local false discovery rates from decoy database searches. | Q51871306 | ||
| Proteomics of buccal squamous cell carcinoma: the involvement of multiple pathways in tumorigenesis. | Q53366489 | ||
| Detection of autoantibodies against cyclophilin A and triosephosphate isomerase in sera from breast cancer patients by proteomic analysis. | Q54474404 | ||
| iTRAQ-multidimensional liquid chromatography and tandem mass spectrometry-based identification of potential biomarkers of oral epithelial dysplasia and novel networks between inflammation and premalignancy. | Q54503698 | ||
| Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics. | Q33196954 | ||
| Correcting common errors in identifying cancer-specific serum peptide signatures | Q33221189 | ||
| Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis | Q33237821 | ||
| Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer. | Q33248782 | ||
| Over-expression of 14-3-3zeta is an early event in oral cancer | Q33296339 | ||
| Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines | Q33628868 | ||
| Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma | Q33794491 | ||
| Salivary proteomics for oral cancer biomarker discovery | Q33879157 | ||
| Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. | Q33883005 | ||
| The cancer cell secretome: a good source for discovering biomarkers? | Q34022076 | ||
| Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology | Q34024261 | ||
| Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell tumours | Q34626026 | ||
| Breast tumor microenvironment: proteomics highlights the treatments targeting secretome | Q34759911 | ||
| The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway | Q34811541 | ||
| Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion | Q35669749 | ||
| Processing of laminin-5 and its functional consequences: role of plasmin and tissue-type plasminogen activator | Q36255285 | ||
| Protein biomarker discovery and validation: the long and uncertain path to clinical utility | Q36561644 | ||
| Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry | Q36713650 | ||
| Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma | Q36914488 | ||
| Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group | Q37128329 | ||
| Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma | Q37294438 | ||
| The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development | Q37332559 | ||
| Protein biomarker discovery for head and neck cancer | Q37688675 | ||
| Role of cyclophilin a during oncogenesis | Q37701332 | ||
| Tumor-host interactions: a far-reaching relationship | Q37774174 | ||
| Mass spectrometry‐based clinical proteomics: Head‐and‐neck cancer biomarkers and drug‐targets discovery | Q37800056 | ||
| Characterization of gene expression in major types of salivary gland carcinomas with epithelial differentiation | Q38332218 | ||
| Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets | Q38515764 | ||
| LC−MS/MS Analysis of Ovarian Cancer Metastasis-Related Proteins Using a Nude Mouse Model: 14-3-3 Zeta as a Candidate Biomarker | Q39638841 | ||
| Secretome-Based Identification and Characterization of Potential Biomarkers in Thyroid Cancer | Q39651203 | ||
| Workflow comparison for label-free, quantitative secretome proteomics for cancer biomarker discovery: method evaluation, differential analysis, and verification in serum | Q39750463 | ||
| Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer | Q39815428 | ||
| Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers | Q39851064 | ||
| Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer. | Q39859123 | ||
| Pathway-based biomarker search by high-throughput proteomics profiling of secretomes | Q39886601 | ||
| P4510 | describes a project that uses | liquid chromatography–mass spectrometry | Q873864 |
| liquid chromatography-tandem mass spectrometry | Q117788892 | ||
| P433 | issue | 12 | |
| P921 | main subject | biomarker | Q864574 |
| head and neck cancer | Q1783924 | ||
| head and neck carcinoma | Q18554836 | ||
| neck cancer | Q18966654 | ||
| P304 | page(s) | 2363-2376 | |
| P577 | publication date | 2011-05-20 | |
| P1433 | published in | Proteomics | Q15614164 |
| P1476 | title | Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: Strategy for discovery of candidate serological biomarkers | |
| P478 | volume | 11 |
| Q28264735 | 14-3-3 zeta as novel molecular target for cancer therapy |
| Q47127196 | 14-3-3ζ Overexpression is Associated with Poor Prognosis in Ovarian Cancer. |
| Q36784639 | 14-3-3ζ as a predictor of early time to recurrence and distant metastasis in hormone receptor-positive and -negative breast cancers |
| Q53121826 | 14-3-3ζ silencing retards tongue squamous cell carcinoma progression by inhibiting cell survival and migration. |
| Q58802465 | A secretome profile indicative of oleate-induced proliferation of HepG2 hepatocellular carcinoma cells |
| Q34279515 | Accumulation of cyclophilin A isoforms in conditioned medium of irradiated breast cancer cells. |
| Q36406560 | Advances in the proteomic investigation of the cell secretome. |
| Q36021076 | Enolase-1 is a therapeutic target in endometrial carcinoma |
| Q33636309 | Estrogen promotes prostate cancer cell migration via paracrine release of ENO1 from stromal cells |
| Q36077903 | Extracellular cyclophilin-A stimulates ERK1/2 phosphorylation in a cell-dependent manner but broadly stimulates nuclear factor kappa B |
| Q38274888 | Extracellular cyclophilins in health and disease |
| Q47716837 | Gaining insights into cancer biology through exploration of the cancer secretome using proteomic and bioinformatic tools. |
| Q36210409 | Global secretome analysis identifies novel mediators of bone metastasis. |
| Q41962920 | Glucose induces rapid changes in the secretome of Saccharomyces cerevisiae |
| Q28647947 | HCSD: the human cancer secretome database |
| Q90705849 | High expression level of peptidylprolyl isomerase A is correlated with poor prognosis of liver hepatocellular carcinoma |
| Q44073007 | How will increasing our knowledge of the head and neck cancer cells' secretome benefit head and neck squamous cell carcinoma patients? |
| Q37616960 | Identification of human tissue kallikrein 6 as a potential marker of laryngeal cancer based on the relevant secretory/releasing protein database |
| Q39440703 | Identification of soluble 14-3-3∊ as a novel subchondral bone mediator involved in cartilage degradation in osteoarthritis. |
| Q39269737 | Implication of 14-3-3ε and 14-3-3θ/τ in proteasome inhibition-induced apoptosis of glioma cells |
| Q33945211 | Integrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disorders |
| Q35013394 | Laser ionization mass spectrometry in oral squamous cell carcinoma. |
| Q39468169 | Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture. |
| Q35037000 | New insight into benign tumours of major salivary glands by proteomic approach |
| Q36386860 | Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy |
| Q35203647 | Proteomic enrichment analysis of psychotic and affective disorders reveals common signatures in presynaptic glutamatergic signaling and energy metabolism |
| Q42109826 | Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance |
| Q39242942 | SILAC-based quantitative proteomic analysis of gastric cancer secretome. |
| Q38949695 | Secreted cyclophilin A mediates G1/S phase transition of cholangiocarcinoma cells via CD147/ERK1/2 pathway |
| Q39210485 | Secretome proteins as candidate biomarkers for aggressive thyroid carcinomas. |
| Q37509713 | Skewed distribution of IL-7 receptor-α-expressing effector memory CD8+ T cells with distinct functional characteristics in oral squamous cell carcinoma |
| Q51039769 | Statistical detection of quantitative protein biomarkers provides insights into signaling networks deregulated in acute myeloid leukemia. |
| Q30525642 | Surveying proteolytic processes in human cancer microenvironments by microdialysis and activity-based mass spectrometry |
Search more.